PHVS
Pharvaris NV
NASDAQ · Healthcare · Biotechnology · NL
$29.77
+7.32%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 109.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.19x
- Price / sales
- —
- Price / cash flow
- -11.94x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- —
- EV / EBITDA
- -8.98x
- EV / EBIT
- -8.44x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026